I.
Introduction:
The exact contributions of postprandial and fasting glucose increments to overall hyperglycemia remain controversial. The glycosylated hemoglobin are minor components of adult hemoglobin which are obtained by cation exchange chromatography. In 1997 and 2003, the Expert Committee on Diagnosis and Classification of Diabetes Mellitus recognized an intermediate group of individuals whose glucose levels do not meet criteria for diabetes, yet are higher than those considered normal. These people were defined as having impaired fasting Glucose (IFG) fasting plasma glucose (FPG) levels 100 mg/dl to125 mg/dl, or impaired glucose tolerance (IGT) 2-h values in the oral glucose tolerance test (OGTT) of 140 mg/dl to 199 mg/dl. Individuals with IFG and/or IGT have been referred to as having pre-diabetes, indicating the relatively high risk for the future development of diabetes.
1 After an extensive review of both established and emerging epidemiological evidence, the International Expert Committee recommended the use of the HbA1C test to diagnose diabetes, with a threshold of ≥ 6.5%. This decision has been affirmed by the ADA in 2010. The established glucose criteria for the diagnosis of diabetes also remain valid. These include the FPG ≥126 mg/dl wherein fasting is defined as no caloric intake for at least 8 h OR 2-h PG ≥200 mg/dl. Additionally, patients with severe hyperglycemia such as those who present with severe classic hyperglycemic symptoms or hyperglycemic crisis can continue to be diagnosed when random (or casual) plasma glucose is ≥ 200 mg/dl.
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The present study is designed to know the relationship of the defined range of various values of glycosylated hemoglobin with fasting and postprandial glycemic status in pre-diabetics and diabetic patient with / without oral hypoglycemic agents.
II. Methods & Material:
402 patients of Diabetes Mellitus were enrolled for this prospective observational study.
Inclusion Criteria:
1. The Patients of type II diabetes mellitus who were receiving oral hypoglycemic agents for more than 3 months. Fasting and postprandial plasma glucose levels are done on a photometric instrument called as "Dimension". The estimation of Glycosylated Hemoglobin levels has been conducted by the NycoCard Kit.
III. Observations And Results:
A total of 402 patients were included in this study. Out of the 402 patients, 205 (51%) are males and 197 (49%) are females. The Mean age for male population is 55.04 ± 13.22 years while that of the female population is 50.50 ± 10.97 years. The Male to female ratio is1.04:1. There is no significant gender variation noted in the overall population. Out of 402 cases studied the maximum incidence of patients occurred in the age group of 41-50 years and the minimum occurred in the age group of 81-90 years. No Female patient is seen in age group of 81-90 years and there is significant difference of gender noted in the age groups of 70 years and above.
The total number of study population is distributed into 5 groups (Quintiles) depending upon their HbA1C levels. There is no significant percentile co-relationship of Gender with HbA1C Quintiles. Table I & Fig. I describes the number of patients in each Quintile of HbA1C. Maximum Number of patients found in Group C (6.5%-8.2 %), whereas the minimum in Group A (≤ 5.6%). The mean value of Fasting Plasma Glucose (FPG) and Postprandial Plasma Glucose (PPG) increases with the increasing quintile of HbA1C. Table II Table IV describes the Obesity Class tends to rise significantly from Healthy to Obese with rising trends of HbA1C Quintiles. Table V shows the occurrence of DR is more with rising trend of HbA1C. The Clinical Grades of Diabetic Retinopathy tends to rise from mild to severe with rising trends of HbA1C quintiles.
Table VI describes The occurrence of Diabetic Neuropathy in Diabetics. It is observed that the occurrence of Diabetic Neuropathy increases with rising trends of HbA1C Quintiles. Even in the pre diabetic range out of 51 cases, 37 had no neuropathy while 14 (27.45%) had clinical evidence of neuropathy. The evidence of neuropathy is noted in the Pre-diabetic as well as the diabetic range, hence neurological examination in cases of pre-diabetics is mandatory even when the individual is asymptomatic.
IV.
Discussion:
The present study with 402 cases is designed to know the relationship of the defined range of various values of glycosylated hemoglobin with fasting and postprandial glycemic status in pre-diabetics and diabetic patient with or without oral hypoglycemic agents. The groups (quintiles) of HbA1C are formed in accordance with the ADA Criteria (2010)
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. A study, conducted by Avignon et al (1997) 7 found that post lunch plasma glucose and extended post lunch plasma glucose was more reliable in predicting poor glycemic control than pre-breakfast or pre-lunch plasma glucose. Similarly, improvements in HbA1C levels were noted in a study by Bastyr et al (2000) 8 , which showed that therapy focused on lowering postprandial glucose found better in lowering glycated hemoglobin levels.
To test the effect of overall glycemic control, Monnier et al (2003) 9 analyzed the diurnal glycemic profiles of type 2 diabetic patients investigated with various quintiles of HbA1C. This study was based on 290 non-insulin-and non-acarbose using patients with type 2 diabetes. Plasma Glucose (PG) concentrations were determined as fasting, postprandial and post-absorptive periods. The authors observed that the relative contribution of postprandial glucose decreased progressively from the lowest 69.7% to the highest quintile of HbA1C 30.5% (P < 0.001), whereas the relative contribution of fasting glucose increased gradually with increasing levels of HbA1C: 30.3% in the lowest vs. 69.5% in the highest quintile (P <0.001). The authors concluded that the relative contribution of postprandial glucose excursions is predominant in fairly controlled patients, whereas the contribution of fasting hyperglycemia increases gradually with diabetes worsening.
In the present study, the total number of study population is distributed into 5 groups (Quintiles) depending upon their HbA1C levels. There is no significant percentile co-relationship of gender with HbA1C quintiles. The mean values of both the Fasting Plasma Glucose (FPG) and the Postprandial Plasma Glucose (PPG) increases with the rising trend of HbA1C quintile (Table I & Fig.I ). Fasting Plasma Glucose is more significantly correlated with the HbA1C levels than the postprandial plasma glucose in the uncontrolled diabetics (Group-E), whereas the postprandial plasma glucose is more significantly correlated in the lower ranges of HbA1C (Group-A & Group-B). In cases of diabetes mellitus in Group-C & Group-D, the r-values for both the FPG and the PPG found equal and significant (Table II and fig. II) .
We conclude that, with the severity of diabetes mellitus in relation to increased HbA1C values, attention should be paid more for better control of Fasting Plasma Glucose. When the values of HbA1C are near normal or in pre-diabetic range, glycemic control should be achieved by controlling postprandial plasma glucose since here fasting plasma glucose is negatively correlated. When the values of HbA1C remain at the moderate limit due attention is needed for controlling both the fasting and the postprandial plasma glucose, judiciously.
Further, significant correlations are noted between the body mass index and the HbA1C level in the patients with diabetes mellitus in Group-C (p=0.007), Group-D (p=0.023) and in Group-E (p=0.004). The obesity class tends to rise significantly from healthy to obese with the rising trends of HbA1C quintiles (Table  IV) . The presence of diabetic retinopathy is significantly noted in 300 (74.62%) cases of the total study population. The clinical grades of diabetic retinopathy tends to rise from mild to severe with rising trends of HbA1C quintiles (Table V) . The presence of diabetic neuropathy is noted in 187 (46.51%) cases of the total study population. Diabetic neuropathy is seen more with rising trends of HbA1C quintiles, (Group-D & E) (Table VI) . In the pre-diabetic range (Group-B) out of 51 patients 14 (27.45%) patients had clinical evidence of diabetic neuropathy. Hence, the neurologic examination in pre-diabetics is mandatory even when the individual is asymptomatic.
V. Conclusion:
With the severity of diabetes mellitus in relation to increased HbA1C values, attention should be paid more for better control of Fasting Plasma Glucose. When the values of HbA1C are near normal or in prediabetic range, glycemic control should be achieved by controlling postprandial plasma glucose since here fasting plasma glucose is negatively correlated. When the values of HbA1C remain at the moderate limit due attention is needed for controlling both the fasting and the postprandial plasma glucose, judiciously. Diabetic neuropathy is seen more with rising trends of HbA1C quintiles. The obesity class tends to rise significantly from healthy to obese with the rising trends of HbA1C quintiles. The clinical grades of diabetic retinopathy tends to rise from mild to severe with rising trends of HbA1C quintiles. Diabetic neuropathy is observed in pre-diabetics and diabetics. Hence, the neurologic examination in pre-diabetics is mandatory even when the individual is asymptomatic. 
